Mohammed Fahad Aldawsari

Pharmacology, Toxicology and Pharmaceutical Science

1. Bioavailability 100%
2. Nanoparticle 97%
3. Cytotoxicity 74%
4. Breast Cancer 70%
5. Pharmacokinetic 60%
6. Sustained Release 52%
7. Drug Release 51%
8. Tablet 49%
9. Rat 43%
10. Drug Delivery System 40%
11. Zeta Potential 37%
12. Malignant Neoplasm 37%
13. Solid Lipid Nanoparticle 34%
14. Ethyl Cellulose 33%
15. Differential Scanning Calorimetry 32%
16. Antiinfective Agent 28%
17. Scanning Electron Microscopy 28%
18. Lipid 27%
19. Nanocarrier 27%
20. Antiproliferative Activity 27%
21. Sildenafil 25%
22. Baricitinib 25%
23. Nanogel 25%
24. Nanoemulsion 23%
25. Chitosan 23%
26. Polyglactin 22%
27. Delafloxacin 21%
28. Wound Healing 21%
29. Pseudomonas aeruginosa 20%
30. IC50 20%
31. Rat Model 18%
32. Colorectal Carcinoma 18%
33. Antimicrobial Agent 17%
34. Osimertinib 17%
35. Glycyrrhizin 17%
36. Bimatoprost 17%
37. Diosmin 17%
38. Silver Nanoparticle 17%
39. Tableting 17%
40. Apigenin 17%
41. Tadalafil 17%
42. Gold Nanoparticle 17%
43. Cyclodextrin 17%
44. Surfactant 16%
45. Non Small Cell Lung Cancer 16%
46. Anti-Inflammatory Drug 15%
47. Antioxidant 14%
48. Anticarcinogen 13%
49. Antibacterial Activity 13%
50. Diseases 13%